Jaguar Health, Inc. (JAGX)
0.319
-0.05
(-12.91%)
USD |
NASDAQ |
Sep 10, 16:00
0.3237
0.00 (0.00%)
After-Hours: 20:00
Jaguar Health EPS Diluted (Quarterly) : -15.70 for June 30, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -15.70 |
| March 31, 2026 | -13.60 |
| December 31, 2025 | -116.40 |
| September 30, 2025 | -219.78 |
| June 30, 2025 | -358.94 |
| March 31, 2025 | -584.45 |
| December 31, 2024 | -657.03 |
| September 30, 2024 | -1.052 |
| June 30, 2024 | -4.040 |
| March 31, 2024 | -3.485 |
| December 31, 2023 | -7.522 |
| September 30, 2023 | -22.50 |
| June 30, 2023 | -41.35 |
| March 31, 2023 | -143.28 |
| December 31, 2022 | -205.78 |
| September 30, 2022 | -529.70 |
| June 30, 2022 | -528.88 |
| March 31, 2022 | -1810.22 |
| December 31, 2021 | -1276.11 |
| September 30, 2021 | -1196.86 |
| June 30, 2021 | -1413.99 |
| March 31, 2021 | -1292.62 |
| December 31, 2020 | -1320.84 |
| September 30, 2020 | -2776.28 |
| Date | Value |
|---|---|
| June 30, 2020 | -5988.06 |
| March 31, 2020 | -7503.44 |
| December 31, 2019 | -1983.42 |
| September 30, 2019 | -26998.52 |
| June 30, 2019 | -204031.4 |
| March 31, 2019 | -227291.4 |
| December 31, 2018 | -184237.2 |
| September 30, 2018 | -480920.0 |
| June 30, 2018 | -718767.0 |
| March 31, 2018 | -732705.8 |
| December 31, 2017 | -2.720M |
| September 30, 2017 | 992250.0 |
| June 30, 2017 | -1.701M |
| March 31, 2017 | -4.678M |
| December 31, 2016 | -3.969M |
| September 30, 2016 | 0.00 |
| June 30, 2016 | -5.027M |
| March 31, 2016 | -6.068M |
| December 31, 2015 | -7.207M |
| September 30, 2015 | -5.166M |
| June 30, 2015 | -14.20M |
| March 31, 2015 | 0.00 |
| June 30, 2014 | -3.563M |
| March 31, 2014 | -3.393M |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Reviva Pharmaceuticals Holdings, Inc. | -0.1853 |
| Jupiter Neurosciences, Inc. | -4.079 |
| ANI Pharmaceuticals, Inc. | 1.052 |
| Corcept Therapeutics, Inc. | 0.356 |
| Veru, Inc. | -0.3032 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -12.80M |
| Revenue (Quarterly) | 1.225M |
| Total Expenses (Quarterly) | 13.91M |
| Enterprise Value | 11.80M |
| Gross Profit Margin (Quarterly) | -22.04% |
| Profit Margin (Quarterly) | -1.05K% |
| Earnings Yield | -114.6K% |
| Normalized Earnings Yield | -98408.71 |